GP
Gandhi Priti Maulik
About Gandhi Priti Maulik
Data last updated:
Gandhi Priti Maulik is a Director at Supersil Architectural Products Private Limited (since 2021), Designated Partner at Pexton Pharma Solutions Llp (since 2023) and Designated Partner at Pexton Life Sciences Llp (since 2019). The companies operate in Machinery and Equipment, Paper and Pharma. The largest current company by reported revenue is Supersil Architectural Products Private Limited at ₹15.89 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 04 Mar 2021 | 2004 | ₹15.89 Cr (FY 2025) | Active | |
| Designated Partner | 29 Mar 2023 | 2023 | Active | ||
| Designated Partner | 10 Jul 2019 | 2019 | Active |
Board colleagues of Gandhi Priti Maulik
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bela Kalpesh Seth | 05159097 | Supersil Architectural Products Private Limited | Director |
| Bhogilal Chunilal Sheth | 00245145 | Supersil Architectural Products Private Limited | Director |
| Kalpesh Bhogilal Sheth | 01958309 | Supersil Architectural Products Private Limited | Director |
| Maulik Jayantilal Gandhi | 05261219 | Supersil Architectural Products Private Limited , Pexton Pharma Solutions Llp and 1 more | Director |
| Amishkumar Navnitlal Sheth | 08505492 | Pexton Pharma Solutions Llp , Pexton Life Sciences Llp | Designated Partner |
| Pulin Ashokkumar Doshi | 00468640 | Pexton Pharma Solutions Llp , Pexton Life Sciences Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Gandhi Priti Maulik
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gandhi Priti Maulik
Gandhi Priti Maulik currently holds 3 directorships: Supersil Architectural Products Private Limited (Director, since 04 Mar 2021, revenue ₹15.89 Cr (FY 2025)); Pexton Pharma Solutions Llp (Designated Partner, since 29 Mar 2023); Pexton Life Sciences Llp (Designated Partner, since 10 Jul 2019).
Gandhi Priti Maulik was first appointed on 10 Jul 2019 as Designated Partner at Pexton Life Sciences Llp. The most recent appointment on record is 29 Mar 2023 at Pexton Pharma Solutions Llp.
The current boards of Gandhi Priti Maulik's companies include Bela Kalpesh Seth (Supersil Architectural Products Private Limited), Bhogilal Chunilal Sheth (Supersil Architectural Products Private Limited), Kalpesh Bhogilal Sheth (Supersil Architectural Products Private Limited), Maulik Jayantilal Gandhi (Supersil Architectural Products Private Limited), Amishkumar Navnitlal Sheth (Pexton Pharma Solutions Llp), Pulin Ashokkumar Doshi (Pexton Pharma Solutions Llp).